416 related articles for article (PubMed ID: 24274980)
1. Type 1 diabetes, metabolic syndrome and cardiovascular risk.
Chillarón JJ; Flores Le-Roux JA; Benaiges D; Pedro-Botet J
Metabolism; 2014 Feb; 63(2):181-7. PubMed ID: 24274980
[TBL] [Abstract][Full Text] [Related]
2. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
Nathan DM;
Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
[TBL] [Abstract][Full Text] [Related]
3. Obesity and type 1 diabetes mellitus management.
Chillarón JJ; Benaiges D; Mañé L; Pedro-Botet J; Flores Le-Roux JA
Minerva Endocrinol; 2015 Mar; 40(1):53-60. PubMed ID: 25413942
[TBL] [Abstract][Full Text] [Related]
4. The science of hypoglycemia in patients with diabetes.
Oyer DS
Curr Diabetes Rev; 2013 May; 9(3):195-208. PubMed ID: 23506375
[TBL] [Abstract][Full Text] [Related]
5. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
Purnell JQ; Zinman B; Brunzell JD;
Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
[TBL] [Abstract][Full Text] [Related]
6. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
; Nathan DM; Zinman B; Cleary PA; Backlund JY; Genuth S; Miller R; Orchard TJ
Arch Intern Med; 2009 Jul; 169(14):1307-16. PubMed ID: 19636033
[TBL] [Abstract][Full Text] [Related]
7. Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profile.
Schwartz SS; Jellinger PS; Herman ME
Postgrad Med; 2016 Aug; 128(6):609-19. PubMed ID: 27210018
[TBL] [Abstract][Full Text] [Related]
8. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
[TBL] [Abstract][Full Text] [Related]
9. [Estimated glucose disposal rate in patients under 18 years of age with type 1 diabetes mellitus and overweight or obesity].
Palomo Atance E; Ballester Herrera MJ; Giralt Muiña P; Ruiz Cano R; León Martín A; Giralt Muiña J
Endocrinol Nutr; 2013; 60(7):379-85. PubMed ID: 23731805
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR.
Schernthaner G
Wien Med Wochenschr; 2010 Jan; 160(1-2):8-19. PubMed ID: 20229156
[TBL] [Abstract][Full Text] [Related]
11. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
[TBL] [Abstract][Full Text] [Related]
12. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
Genuth S
Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
[TBL] [Abstract][Full Text] [Related]
13. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
14. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.
Kilpatrick ES; Rigby AS; Atkin SL
Diabetes Care; 2007 Mar; 30(3):707-12. PubMed ID: 17327345
[TBL] [Abstract][Full Text] [Related]
16. [Glycemic targets and cardiovascular morbi-mortality].
Bordier L; Bauduceau B
Presse Med; 2013 May; 42(5):855-60. PubMed ID: 23286961
[TBL] [Abstract][Full Text] [Related]
17. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
[TBL] [Abstract][Full Text] [Related]
18. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
19. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.
Blasetti A; Di Giulio C; Tocco AM; Verrotti A; Tumini S; Chiarelli F; Altobelli E
Pediatr Diabetes; 2011 Feb; 12(1):4-10. PubMed ID: 20723102
[TBL] [Abstract][Full Text] [Related]
20. Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System.
Felício KM; de Souza ACCB; Neto JFA; de Melo FTC; Carvalho CT; Arbage TP; de Rider Brito HA; Peixoto AS; de Oliveira AF; de Souza Resende F; Reis SS; Motta AR; da Costa Miranda H; Janau LC; Yamada ES; Felicio JS
Curr Diabetes Rev; 2018; 14(4):395-403. PubMed ID: 28618984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
